European Union

May 9, 2026
Implementing Sustainable Liver Health in Europe: A Second EASL–Lancet Commission
In December 2021, the European Association for the Study of the Liver (EASL)–Lancet Commission on liver disease in Europe launched its first report, which highlighted an alarming increase in liver-related mortality in many European countries. The Commission proposed a roadmap for addressing the documented negative trends. However, quoting one of the accompanying Comment articles, “gaining consensus […]

Read More
September 2, 2025
Estimating the Impact of Displacement from Ukraine on HBV and HCV Prevalence Among Migrants in the European Union, 2024: A Modeling Study
Summary Background In countries with low baseline burdens of hepatitis B and C viruses (HBV, HCV), high levels of migration can impact the burden of viral hepatitis. The screening and treatment of migrants requires different methods and sensitivities than broad-based programs. We aimed to estimate the prevalence of HBV and HCV among migrants in EU-27 […]

Read More

English